Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38262
CAS Number:
674773-07-0
Strontium ranelate hydrate
Purity:
≥ 98% (HPLC)
Synonym(s):
Ranelic acid Strontium salt hydrate
Documents
$115.27 /1G
Pack Size Availability Price
Request Bulk Quote
Product Information

Strontium ranelate hydrate is a unique compound recognized for its potential in the treatment of osteoporosis and bone health enhancement. This innovative therapeutic agent functions by promoting bone formation while simultaneously inhibiting bone resorption, making it a valuable option for patients at risk of fractures. Its dual action is particularly beneficial in managing conditions associated with low bone density, providing a comprehensive approach to bone health. Researchers and healthcare professionals appreciate its ability to improve bone mineral density and reduce the incidence of vertebral and non-vertebral fractures, which is crucial for patient care in geriatric populations.

In addition to its medical applications, strontium ranelate hydrate is also being explored in various research settings for its potential in biomaterials and regenerative medicine. Its unique chemical structure allows for versatile applications, including the development of new therapeutic strategies for bone-related disorders. The compound's stability and efficacy make it an attractive candidate for further studies, paving the way for advancements in both clinical and research environments.

Synonyms
Ranelic acid Strontium salt hydrate
CAS Number
674773-07-0
Purity
≥ 98% (HPLC)
Molecular Formula
C12H6N2O8SSr2·xH2O
Molecular Weight
513.49
MDL Number
MFCD09038742
PubChem ID
57329986
Appearance
White to light yellow powder to crystal
Conditions
Store at < 0 °C
General Information
Synonyms
Ranelic acid Strontium salt hydrate
CAS Number
674773-07-0
Purity
≥ 98% (HPLC)
Molecular Formula
C12H6N2O8SSr2·xH2O
Molecular Weight
513.49
MDL Number
MFCD09038742
PubChem ID
57329986
Appearance
White to light yellow powder to crystal
Conditions
Store at < 0 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Strontium ranelate hydrate is widely utilized in research focused on:

  • Osteoporosis Treatment: This compound is primarily used in the pharmaceutical industry for the treatment of osteoporosis, helping to increase bone density and reduce fracture risk in postmenopausal women.
  • Bone Health Research: Researchers use strontium ranelate hydrate to study its effects on bone metabolism, providing insights into how it can enhance bone formation and inhibit bone resorption.
  • Drug Formulation Development: In the development of new medications, this compound serves as a model for creating effective formulations aimed at improving bioavailability and therapeutic efficacy.
  • Clinical Trials: It is frequently used in clinical trials to evaluate its long-term safety and effectiveness, contributing to the advancement of treatment protocols for osteoporosis.
  • Comparative Studies: Strontium ranelate hydrate is often compared with other osteoporosis treatments, allowing researchers to assess its unique advantages, such as a dual mode of action that supports both bone formation and decreases bone resorption.

Citations